InsiderTrades

Form 4/A for NEO NEOGENOMICS INC

Accepted 2024-12-04 00:00:00 ET · period of report 2024-05-11 · accession 0001077183-24-000169 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DA 2024-12-04 2024-05-11 NEO Sherman Jeffrey Scott CFO F - Tax $14.86 -3,167 135.5K -2% -$47.1K
DA 2024-12-04 2024-05-11 NEO Sherman Jeffrey Scott CFO M - OptEx $0.00 +13.0K 138.7K +10% $0
DA 2024-12-04 2024-05-11 NEO Sherman Jeffrey Scott CFO M - OptEx $0.00 -13.0K 26.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-11 F D 3,167 $14.86 135,500 D — — (F2) Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. (F3) On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares of common stock received upon the vesting of certain of his RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 135,500 shares of common stock after the vesting of 13,005 RSUs and reported withholding.
2 Common Common Stock 2024-05-11 M A 13,005 $0.00 138,667 D — — (F1) Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
3 Derivative Restricted Stock Unit 2024-05-11 M D 13,005 $0.00 26,011 D $0.00 · — to — 13,005 Common Stock (F4) On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date. (F5) Once vested, the shares of common stock are not subject to expiration.